Veeva Systems (VEEV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
11 Jan, 2026Executive summary
Q3 2025 revenue reached $699 million, up 13% year-over-year, with non-GAAP operating income of $304 million and a record 43.5% margin, both above guidance.
Subscription services drove growth, accounting for 83% of revenue and rising 17% year-over-year, while services revenue declined slightly.
Significant milestones included Vault CRM's fourth top 20 biopharma commitment, over 30 customers live, and new GenAI solutions like CRM Bot and MLR Bot.
Strong liquidity position with $5.1 billion in cash, cash equivalents, and short-term investments as of October 31, 2024.
FY 2025 guidance projects total revenue of $2,722–$2,725 million and non-GAAP operating income of ~$1,120 million.
Financial highlights
Total revenue for Q3 2025 was $699 million, up 13% year-over-year; subscription revenue grew 17% to $581 million, while services revenue declined 3%.
Non-GAAP operating income was $304 million, with a margin of 43.5%; GAAP operating income was $181 million, up 41% year-over-year.
Gross margin improved to 75% GAAP and 77.3% non-GAAP; subscription gross margin was 86.2%.
Net income for the quarter was $186 million, up 37% year-over-year; diluted EPS was $1.13.
Cash flow from operations for the nine months was $1.02 billion.
Outlook and guidance
FY 2025 revenue guidance is $2,722–$2,725 million, with non-GAAP operating income of ~$1,120 million and non-GAAP EPS of ~$6.44.
Q4 2025 revenue guidance is $696–$699 million, with non-GAAP operating income of $275 million and EPS of ~$1.57.
Management expects R&D Solutions to continue increasing as a share of total revenues.
No formal FY2026 guidance yet; will be provided after Q4 results.
Cash flows from operating activities expected to be lower in Q4 due to seasonality and tax payments.
Latest events from Veeva Systems
- FY 2026 revenue and net income rose sharply, with robust outlook and accelerating AI-driven growth.VEEV
Q4 20265 Mar 2026 - All proposals were recommended for approval, with voting results to be filed publicly.VEEV
AGM 20243 Feb 2026 - Growth accelerates as unified platform, AI, and new products expand market share and customer value.VEEV
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Integrated platform and data innovation fuel durable growth and leadership in life sciences.VEEV
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q2 revenue up 15% year-over-year, with strong margins and raised FY2025 guidance.VEEV
Q2 202523 Jan 2026 - Vault CRM and unified platforms drive growth as life sciences invests in innovation.VEEV
Citi's 2024 Global TMT Conference22 Jan 2026 - 2030 revenue goal set at $6B, with organic growth and new market expansion as key drivers.VEEV
Investor Day 202415 Jan 2026 - AI-driven life sciences cloud growth targets $6B revenue and diversified leadership by 2030.VEEV
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Integrated innovation and disciplined growth drive confidence in $6B revenue targets by 2030.VEEV
Raymond James 2024 TMT & Consumer Conference11 Jan 2026